Skip to main content

Articles

Page 320 of 337

  1. It has recently been shown that NDRG2 mRNA is down-regulated or undetectable in several human cancers and cancer cell-lines. Although the function of NDRG2 is unknown, high NDRG2 expression correlates with improv...

    Authors: Anders Lorentzen, Lotte K Vogel, Rikke H Lewinsky, Mona Sæbø, Camilla F Skjelbred, Sine Godiksen, Geir Hoff, Kjell M Tveit, Inger Marie Bowitz Lothe, Tone Ikdahl, Elin H Kure and Cathy Mitchelmore
    Citation: BMC Cancer 2007 7:192
  2. A verifiable consequence of the mutator hypothesis is that even low grade neoplasms would accumulate a large number of mutations that do not influence the tumor phenotype (clonal mutations). In this study, we ...

    Authors: Anjan Misra, Parthaprasad Chattopadhyay, Kunzang Chosdol, Chitra Sarkar, Ashok K Mahapatra and Subrata Sinha
    Citation: BMC Cancer 2007 7:190
  3. Matrix metalloproteinase (MMP) is known to be involved in the initial and progressive stages of cancer development, and in the aggressive phenotypes of cancer. This study examines the association of single nucleo...

    Authors: Rishiho Nishizawa, Masaki Nagata, Arhab A Noman, Nobutaka Kitamura, Hajime Fujita, Hideyuki Hoshina, Takehiko Kubota, Manami Itagaki, Susumu Shingaki, Makoto Ohnishi, Hiroshi Kurita, Kouji Katsura, Chikara Saito, Hiromasa Yoshie and Ritsuo Takagi
    Citation: BMC Cancer 2007 7:187
  4. A set of consistent, standardized definitions of intervals and populations on which to report across provinces is needed to inform the Provincial/Territorial Deputy Ministries of Health on progress of the Ten-...

    Authors: Marcy Winget, Donna Turner, Jon Tonita, Charlotte King, Zoann Nugent, Riaz Alvi and Richard Barss
    Citation: BMC Cancer 2007 7:186
  5. Lymphomatous meningitis (LM) represents a severe complication of malignant lymphomas. While clinical suspicion is raised by symptoms ranging from mild disturbances of sensation to severe pain or impaired consc...

    Authors: B Hildebrandt, C Müller, A Pezzutto, PT Daniel, B Dörken and C Scholz
    Citation: BMC Cancer 2007 7:185
  6. Despite significant advancement in breast cancer therapy, there is a great need for a better understanding of the mechanisms involved in breast carcinogenesis and progression, as well as of the role of epigene...

    Authors: Esteban N Gurzov, Sanaa M Nabha, Hamilto Yamamoto, Hong Meng, O Graciela Scharovsky and R Daniel Bonfil
    Citation: BMC Cancer 2007 7:184
  7. Dietary isothiocyanates (ITCs) are electrophilic compounds that have diverse biological activities including induction of apoptosis and effects on cell cycle. They protect against experimental carcinogenesis i...

    Authors: Janet V Cross, Frank W Foss, Joshua M Rady, Timothy L Macdonald and Dennis J Templeton
    Citation: BMC Cancer 2007 7:183
  8. Published prognostic gene signatures in breast cancer have few genes in common. Here we provide a rationale for this observation by studying the prognostic power and the underlying biological pathways of diffe...

    Authors: Jack X Yu, Anieta M Sieuwerts, Yi Zhang, John WM Martens, Marcel Smid, Jan GM Klijn, Yixin Wang and John A Foekens
    Citation: BMC Cancer 2007 7:182
  9. The sex hormone estrogen (E2) is pivotal to normal mammary gland growth and differentiation and in breast carcinogenesis. In this in silico study, we examined metabolic differences between ER(+)ve breast cancer c...

    Authors: Soma Mandal and James R Davie
    Citation: BMC Cancer 2007 7:181
  10. Feline mammary carcinoma has been proposed as a natural model of highly aggressive, hormone-independent human breast cancer. To further explore the utility of the model by adding new similarities between the t...

    Authors: Javier Ordás, Yolanda Millán, Rafaela Dios, Carlos Reymundo and Juana Martín de las Mulas
    Citation: BMC Cancer 2007 7:179
  11. For patients suffering of recurrent breast cancer within the irradiated breast, generally mastectomy is recommended. The normal tissue tolerance does not permit a second full-dose course of radiotherapy to the...

    Authors: Uta Kraus-Tiefenbacher, Lelia Bauer, Antonella Scheda, Carola Schoeber, Joerg Schaefer, Volker Steil and Frederik Wenz
    Citation: BMC Cancer 2007 7:178
  12. The present study evaluates the outcome of 19 children with rhabdomyosarcoma of the head-and-neck region treated with Intensity Modulated Radiotherapy (IMRT) or Fractionated Stereotactic Radiotherapy (FSRT) be...

    Authors: Stephanie E Combs, Wolfgang Behnisch, Andreas E Kulozik, Peter E Huber, Jürgen Debus and Daniela Schulz-Ertner
    Citation: BMC Cancer 2007 7:177
  13. Interleukin-8 (IL-8) is a cytokine that plays an important role in tumor progression in a variety of cancer types; however, its regulation is not well understood in oral cancer cells. In the present study, we ...

    Authors: Hwa-Jeong Lee, Jun Lee, Sun-Kyung Lee, Suk-Keun Lee and Eun-Cheol Kim
    Citation: BMC Cancer 2007 7:176
  14. Previously, 50% of patients with breast ductal carcinoma in situ (DCIS) had more than one nuclear grade, and neither worst nor predominant nuclear grade was significantly associated with development of invasive c...

    Authors: Judith-Anne W Chapman, Naomi A Miller, H Lavina A Lickley, Jin Qian, William A Christens-Barry, Yuejiao Fu, Yan Yuan and David E Axelrod
    Citation: BMC Cancer 2007 7:174
  15. The host immunogenetic background plays an important role in the development of breast cancer. Cytotoxic T-lymphocyte antigen-4 (CTLA-4) is a molecule expressed predominantly on activated T cells and is import...

    Authors: Lihong Wang, Dalin Li, Zhenkun Fu, Heng Li, Wei Jiang and Dianjun Li
    Citation: BMC Cancer 2007 7:173
  16. The prognosis of patients with hepatocellular carcinoma (HCC) still remains very dismal, which is mainly due to metastasis. In our previous studies, we found that chromosome 8p deletions might contribute to me...

    Authors: Ke-Feng Lei, Yan-Fang Wang, Xiao-Qun Zhu, Peng-Cheng Lu, Bing-Sheng Sun, Hu-Liang Jia, Ning Ren, Qing-Hai Ye, Hui-Chuan Sun, Lu Wang, Zhao-You Tang and Lun-Xiu Qin
    Citation: BMC Cancer 2007 7:172
  17. Contrast enhanced ultrasound (CEUS) is an imaging technique which appeared on the market around the year 2000 and proposed for the detection of liver metastases in gastrointestinal cancer patients, a setting i...

    Authors: Fabio Piscaglia, Francesco Corradi, Mikaela Mancini, Francesco Giangregorio, Stefano Tamberi, Giampaolo Ugolini, Bruno Cola, Alberto Bazzocchi, Roberto Righini, Patrizia Pini, Fabio Fornari and Luigi Bolondi
    Citation: BMC Cancer 2007 7:171
  18. Male breast cancer (MBC) is a rare disease and little is known about its aetiology. Germ-line mutations of BRCA2 and, at lower frequency, of BRCA1 are implicated in a relatively small proportion of MBC cases. Com...

    Authors: Domenico Palli, Mario Falchetti, Giovanna Masala, Ramona Lupi, Francesco Sera, Calogero Saieva, Cristina D'Amico, Marco Ceroti, Piera Rizzolo, Maria Adelaide Caligo, Ines Zanna and Laura Ottini
    Citation: BMC Cancer 2007 7:170
  19. The functional and clinical significance of 14-3-3 proteins in human cancers remain largely undetermined. Earlier, we have reported differential expression of 14-3-3ζ mRNA in oral squamous cell carcinoma (OSCC...

    Authors: Ajay Matta, Sudhir Bahadur, Ritu Duggal, Siddhartha D Gupta and Ranju Ralhan
    Citation: BMC Cancer 2007 7:169
  20. p53 is commonly inactivated by mutations in the DNA-binding domain in a wide range of cancers. As mutant p53 often influences response to therapy, effective and rapid methods to scan for mutations in TP53 are lik...

    Authors: Michael Krypuy, Ahmed Ashour Ahmed, Dariush Etemadmoghadam, Sarah J Hyland, Anna deFazio, Stephen B Fox, James D Brenton, David D Bowtell and Alexander Dobrovic
    Citation: BMC Cancer 2007 7:168
  21. Many patients suffer from severe shoulder complaints after breast cancer surgery and axillary lymph node dissection. Physiotherapy has been clinically observed to improve treatment of these patients. However, ...

    Authors: Carien HG Beurskens, Caro JT van Uden, Luc JA Strobbe, Rob AB Oostendorp and Theo Wobbes
    Citation: BMC Cancer 2007 7:166
  22. Inflammatory cells in the tumour stroma has gained increasing interest recently. Thus, we aimed to study the frequency and prognostic impact of stromal mast cells and tumour infiltrating eosinophils in invasiv...

    Authors: Rose-Marie Amini, Kirsimari Aaltonen, Heli Nevanlinna, Ricardo Carvalho, Laura Salonen, Päivi Heikkilä and Carl Blomqvist
    Citation: BMC Cancer 2007 7:165
  23. Polymorphisms in DNA repair genes have been associated to repair DNA lesions, and might contribute to the individual susceptibility to develop different types of cancer. Nucleotide excision repair (NER), base ...

    Authors: M Felicitas López-Cima, Patricia González-Arriaga, Laura García-Castro, Teresa Pascual, Manuel G Marrón, Xose S Puente and Adonina Tardón
    Citation: BMC Cancer 2007 7:162
  24. Induction of apoptosis is one strategy for treatment of prostate cancer. The Shb adapter protein has been found to regulate apoptosis in various cell types and consequently human prostate cancer 3 (PC3) cells ...

    Authors: Padideh Davoodpour, Maréne Landström and Michael Welsh
    Citation: BMC Cancer 2007 7:161
  25. Young women presenting with breast cancer are more likely to have a genetic predisposition to the disease than breast cancer patients in general. A genetic predisposition is known to increase the risk of new p...

    Authors: Diana Eccles, Sue Gerty, Peter Simmonds, Victoria Hammond, Sarah Ennis and Douglas G Altman
    Citation: BMC Cancer 2007 7:160
  26. Interferon-α (IFN-α) is one of the central agents in immunotherapy for renal cell carcinoma (RCC) and binds to the IFN-α receptor (IFNAR). We investigated the role of IFNAR in RCC.

    Authors: Takao Kamai, Yoshiaki Yanai, Kyoko Arai, Hideyuki Abe, Tomonori Yamanishi, Masashi Kurimoto and Ken-Ichiro Yoshida
    Citation: BMC Cancer 2007 7:159
  27. Interferons are a group of proteins that trigger multiple responses including prevention of viral replication, inhibition of cell growth, and modulation of cell differentiation. In different mammary carcinoma ...

    Authors: Ignacio García-Tuñón, Mónica Ricote, Antonio Ruiz A, Benito Fraile, Ricardo Paniagua and Mar Royuela
    Citation: BMC Cancer 2007 7:158
  28. Adenoid Cystic Carcinoma (ACC) is a rare tumor entity and comprises about 1% of all malignant tumor of the oral and maxillofacial region. It is slow growing but a highly invasive cancer with a high recurrence ...

    Authors: Amal Abdul-Hussein, Pierre A Morris and Tsveti Markova
    Citation: BMC Cancer 2007 7:157
  29. Histological phenotype and clinical behaviour of malignant tumours are not only dependent on alterations in the epithelial cell compartment, but are affected by their interaction with inflammatory cells and tu...

    Authors: David Bacman, Susanne Merkel, Roland Croner, Thomas Papadopoulos, Wolfgang Brueckl and Arno Dimmler
    Citation: BMC Cancer 2007 7:156
  30. Combination of platinum derivatives with paclitaxel is currently the standard front line regimen for patients with epithelial ovarian carcinoma, and represents also an active regimen in patients with metastati...

    Authors: Bohuslav Melichar, Radomír Hyšpler, Emanuela Dragounová, Josef Dvořák, Hana Kalábová and Alena Tichá
    Citation: BMC Cancer 2007 7:155
  31. Colorectal cancer (CRC) diagnosis and the ensuing treatments can have a substantial impact on the physical and psychological health of survivors. As the number of CRC survivors increases, so too does the need ...

    Authors: Rosalind R Spence, Kristiann C Heesch, Elizabeth G Eakin and Wendy J Brown
    Citation: BMC Cancer 2007 7:154
  32. Breast cancer is the most common cancer in women in the U.S. and Western Europe. Amplification of the her-2/neu gene occurs in approximately 25% of invasive ductal carcinomas of the breast. The first HER-2/neu...

    Authors: Gustavo A Viani, Sergio L Afonso, Eduardo J Stefano, Ligia I De Fendi and Francisco V Soares
    Citation: BMC Cancer 2007 7:153
  33. Erlotinib is a Human Epidermal Growth Factor Receptor Type 1/tyrosine kinase (EGFR) inhibitor which is used for non-small-cell lung cancer treatment. Despite that erlotinib is considered to have a favorable sa...

    Authors: Demosthenes Makris, Arnaud Scherpereel, Marie Christine Copin, Guillaume Colin, Luc Brun, Jean Jacques Lafitte and Charles Hugo Marquette
    Citation: BMC Cancer 2007 7:150
  34. C4-2 prostate cancer (CaP) cells grown in mouse tibiae cause a mixed osteoblastic/osteolytic response with increases in osteoclast numbers and bone resorption. Administration of osteoprotegerin (OPG) blocks th...

    Authors: Colm Morrissey, Paul L Kostenuik, Lisha G Brown, Robert L Vessella and Eva Corey
    Citation: BMC Cancer 2007 7:148
  35. The use of combined positron emission tomography/computerised tomography (PET/CT) scanners in oncology has been shown to improve the staging of tumours and the detection of relapses. However, mis-registration ...

    Authors: Jayson Wang, Gary Cook, John Frank, Roberto Dina, Naomi Livni, John Lynn, William Fleming and Michael J Seckl
    Citation: BMC Cancer 2007 7:147
  36. c-Jun/AP-1 has been linked to invasive properties of aggressive breast cancer. Recently, it has been reported that overexpression of c-Jun in breast cancer cell line MCF-7 resulted in increased AP-1 activity, ...

    Authors: Yan Zhang, Xiaoyun Pu, Ming Shi, Liyong Chen, Yuhua Song, Lu Qian, Guogang Yuan, Hao Zhang, Ming Yu, Meiru Hu, Beifen Shen and Ning Guo
    Citation: BMC Cancer 2007 7:145
  37. Synoptic reporting, either as part of the pathology report or replacing some free text component incorporates standardized data elements in the form of checklists for pathology reporting. This ensures the path...

    Authors: Sambit K Mohanty, Anthony L Piccoli, Lisa J Devine, Ashokkumar A Patel, Gross C William, Sharon B Winters, Michael J Becich and Anil V Parwani
    Citation: BMC Cancer 2007 7:144
  38. Squamous cell carcinoma of the head and neck (SCCHN) often contain highly radioresistant hypoxic regions, nonetheless, radiotherapy is a common treatment modality for these tumours. Reoxygenation during fracti...

    Authors: Daniela Schilling, Christine Bayer, Anneke Geurts-Moespot, Fred CGJ Sweep, Martin Pruschy, Karin Mengele, Lisa D Sprague and Michael Molls
    Citation: BMC Cancer 2007 7:143

Featured videos

View featured videos from across the BMC-series journals